Integrated Quantitative Investments »

Neuropace shares owned by Integrated Quantitative Investments

Quarter-by-quarter ownership of Neuropace (NPCE) shares owned by Integrated Quantitative Investments from 13F filings

Historical chart of Integrated Quantitative Investments investment in Neuropace

Tip: Access up to 7 years of quarterly data

All positions including Neuropace held by Integrated Quantitative Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neuropace by Integrated Quantitative Investments

Quarter filed Position value Share count Share price at filing
2026-03-31 $276k 21k 13.15

More positions owned by Integrated Quantitative Investments

Taiwan Semiconductor Manufac Sponsored Ads (TSM)
NVIDIA Corporation (NVDA)
Banco Santander Sa Adr (SAN)
Apple (AAPL)
Shell Spon Ads (SHEL)
Banco Bilbao Vizcaya Argenta Sponsored Adr (BBVA)
Alphabet Cap Stk Cl A (GOOGL)
Ing Groep Sponsored Adr (ING)
GSK Sponsored Adr (GSK)
Mizuho Financial Group Sponsored Adr (MFG)
Alibaba Group Hldg Sponsored Ads (BABA)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Lloyds Banking Group Sponsored Adr (LYG)
Toyota Motor Corp Ads (TM)

View all positions for Integrated Quantitative Investments

Top funds holding Neuropace

Soleus Capital Management
Polar Capital Holdings
Morgan Stanley
First Light Asset Management
BlackRock
OrbiMed Advisors
Driehaus Capital Management
Vanguard Group
Vanguard Capital Management
Deutsche Bank Aktiengesellschaft
Armistice Capital
FMR
Geode Capital Management
State Street Corporation
Silvercrest Asset Management Group

View all funds holding Neuropace